⌘K
Loading ticker…
As of 2026-08-24, CalciMedica, Inc. Common Stock (CALC) has a 3-month relative strength percentile of 28 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.8%, relative volume 0.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CALC is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -27.8% / -69.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CALC is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $48K notional.
Held by 2 ETFs · $91K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $48K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $43K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CALC Jan avg: 15.37% median: -27.68% win: 33% σ: 128.76% n: 3 2023-03-22 → 2026-07-31 | CALC Feb avg: -32.35% median: -41.13% win: 0% σ: 16.53% n: 3 2023-03-22 → 2026-07-31 | CALC Mar avg: -8.85% median: -9.49% win: 25% σ: 11.10% n: 4 2023-03-22 → 2026-07-31 | CALC Apr avg: 9.73% median: 9.26% win: 67% σ: 27.77% n: 3 2023-03-22 → 2026-07-31 | CALC May avg: 15.51% median: 8.92% win: 67% σ: 20.48% n: 3 2023-03-22 → 2026-07-31 | CALC Jun avg: -7.61% median: -13.12% win: 25% σ: 24.48% n: 4 2023-03-22 → 2026-07-31 | CALC Jul avg: 29.33% median: 7.51% win: 50% σ: 58.53% n: 4 2023-03-22 → 2026-07-31 | CALC Aug avg: -15.02% median: -12.85% win: 0% σ: 5.72% n: 3 2023-03-22 → 2026-07-31 (current) | CALC Sep avg: 2.45% median: 6.24% win: 67% σ: 13.76% n: 3 2023-03-22 → 2026-07-31 | CALC Oct avg: -12.51% median: -16.48% win: 0% σ: 7.58% n: 3 2023-03-22 → 2026-07-31 | CALC Nov avg: 42.05% median: 44.26% win: 67% σ: 47.73% n: 3 2023-03-22 → 2026-07-31 | CALC Dec avg: 8.62% median: 2.61% win: 67% σ: 43.02% n: 3 2023-03-22 → 2026-07-31 |